Possible Benefit of Angiotensin II Receptor Blockers in COVID-19 Patients: A Case Series.

Published in: Journal of the renin-angiotensin-aldosterone system : JRAAS (2021)

This report supports the potential benefit of ARBs to improve the clinical outcomes of COVID-19 patients by controlling RAAS dysfunction.

Keyphrases